Latest Insider Transactions at Elevation Oncology, Inc. (ELEV)
This section provides a real-time view of insider transactions for Elevation Oncology, Inc. (ELEV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Elevation Oncology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Elevation Oncology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2021
|
Ven Bio Global Strategic Fund Iii, L.P. |
BUY
Conversion of derivative security
|
Direct |
1,983,167
+50.0%
|
-
|
|
Jun 29
2021
|
Aisling Capital Iv, LP |
BUY
Open market or private purchase
|
Direct |
187,500
+6.2%
|
$3,000,000
$16.0 P/Share
|
|
Jun 29
2021
|
Aisling Capital Iv, LP |
BUY
Conversion of derivative security
|
Direct |
2,351,592
+30.57%
|
-
|
|
Jun 29
2021
|
Qiming U.S. Healthcare Fund Ii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
312,500
+11.65%
|
$5,000,000
$16.0 P/Share
|
|
Jun 29
2021
|
Qiming U.S. Healthcare Fund Ii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,057,642
+33.16%
|
-
|
|
Jun 29
2021
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
250,000
+10.07%
|
$4,000,000
$16.0 P/Share
|
|
Jun 29
2021
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
1,983,168
+50.0%
|
-
|
|
Jun 29
2021
|
Vertex Global Hc Fund Ii Pte. Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
250,000
+9.77%
|
$4,000,000
$16.0 P/Share
|
|
Jun 29
2021
|
Vertex Global Hc Fund Ii Pte. Ltd. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,057,642
+33.16%
|
-
|